HomeProductsBioactive CompoundsProtein Kinase TargetsVEGFRBucillamine
Chemical structure of CAS 65002-17-7

Bucillamine

In Stock•Starting at $66 for 100 mg•Purity ≥ 95%
CAS No.65002-17-7
MDL No.MFCD00867570
MFC7H13NO3S2
MW223.30
InChI KeyVUAFHZCUKUDDBC-BYPYZUCNSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
100 mg95%$66In Stock
250 mg95%$116In Stock
1 g95%$298In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Bucillamine is an organic compound.

CAS No.65002-17-7
Product NameBucillamine

Associated Conditions

gout·cystinuria·rheumatoid arthritis·rheumatic disease·COVID-19
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitization.

Journal of immunology (Baltimore, Md. : 1950) • Vol. 168, Issue 5 • 2002
PMID: 11859152DOI: 10.4049/jimmunol.168.5.2560

Novel therapy in the treatment of scleroderma.

Expert opinion on investigational drugs • Vol. 10, Issue 1 • 2001
PMID: 11116279DOI: 10.1517/13543784.10.1.31

Subcorneal pustular dermatosis-type IgA pemphigus induced by thiol drugs.

European journal of dermatology : EJD • Vol. 11, Issue 1 • 2001
PMID: 11174137

Drug-induced pemphigus foliaceus with features of pemphigus vulgaris.

The British journal of dermatology • Vol. 144, Issue 2 • 2001
PMID: 11251589DOI: 10.1046/j.1365-2133.2001.04043.x

Documentation

Similar Products